The incidence of cardiovascular disease (CVD) events has been reported to be higher in winter than summer.^[@CIT0001]^ Increased blood pressure (BP) induced by vasoconstriction due to exposure to cold temperature during winter, has been considered as one of various mechanisms in the increased CVD incidence.^[@CIT0003]^

Home BP (HBP) measurement has been well accepted as a useful tool in the management of hypertension. It has been reported that HBP has stronger relationship with target organ damage (TOD) and cardiovascular outcomes than office BP.^[@CIT0004]^ Although international guidelines recommend that HBP measurement be conducted both in morning and evening,^[@CIT0008],[@CIT0009]^ elevated morning HBP is more strongly associated with TOD and cardiovascular events than evening HBP.^[@CIT0007],[@CIT0010],[@CIT0011]^ However, these previous findings have not taken seasonal variations into account.

Several studies have demonstrated seasonal variation in HBP---namely, HBP was found to be higher in winter than summer.^[@CIT0012]^ Therefore, the prevalence of masked hypertension (i.e., elevated HBP despite normal office BP) may also increase in winter. Moreover, when the exposure to cold temperature in winter overlaps with elevated BP in morning, this morning period is subject to worse conditions for certain organs. Thus, elevated morning HBP in winter may pose a higher cardiovascular risk than elevated morning HBP in other seasons. Although one previous study reported that the difference between HBP levels in summer and winter was correlated with CVD incidence,^[@CIT0015]^ the results of that study do not answer our above-stated research questions. Therefore, we hypothesized that the association between HBP and TOD would be amplified in winter and in morning.

To test this hypothesis, we used the dataset of the Japan Morning Surge-Home Blood Pressure (J-HOP) study, a nationwide, multicenter prospective study of outpatients in clinical practice. J-HOP study participants conducted HBP measurements in morning and evening and measured their own urine albumin-to-creatinine ratio (UACR) and serum B-type natriuretic peptide (BNP) as markers of TOD. In this study, we analyzed the database of J-HOP study to identify potential seasonal differences in each of HBP, the prevalence of masked hypertension, and the association of HBP with TOD.

METHODS {#s1}
=======

Study design {#s2}
------------

The present study is a cross-sectional observational study and *post hoc* analysis of the J-HOP study. Details of the J-HOP study rationale, design, and procedures have been published.^[@CIT0006]^ Briefly, 4,310 patients with a history or risk factors of CVD were recruited in 71 institutions throughout Japan between 2005 and 2012 ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"} online). Participants measured their own HBP on 14 consecutive days and then were followed-up for CVD events. The present study aimed to assess the seasonal variation of HBP measured at study enrollment and its association with TOD. The Institutional Review Board of Jichi Medical University School of Medicine approved the methods, and all of the patients provided written informed consent to participate and to have their data published.

BP measurements {#s3}
---------------

We assessed office BP and self-measured HBP. Three office BP readings were taken at 15-s intervals on two different occasions within 2 months, and the mean of these six readings was used as the patient's office BP value. Office BP was recorded on two different occasions: before and after the self-measured HBP. Self-measured HBP was performed according to the Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH2014), which were applied during the J-HOP study's period.^[@CIT0016]^ Three HBP readings were taken at 15-s intervals with patients in a seated position in both morning (within 1 h of waking and before taking antihypertensive medications) and evening (before going to bed) for 14 consecutive days. The first day's HBP measurements were excluded, and the averages of the remaining HBP readings (mean ± SD, 11.2 ± 2.7 days) were used to calculate mean HBP levels. The office and HBP values were measured using the same validated, automatic, and oscillometric device (HEM-5001; Omron Healthcare, Kyoto, Japan). To avoid reporting bias, BP data were automatically stored in the memory of the device and were downloaded to a computer by a physician or nurse during office visits. Moreover, we also assessed masked morning/evening hypertension and white-coat morning/evening hypertension in each season, which were defined based on the Japanese hypertension guidelines that were in effect during the study period: masked morning/evening hypertension, office BP \<140/90 mm Hg and morning or evening HBP ≥135/85 mm Hg, respectively; white-coat morning/evening hypertension, office BP ≥140/90 mm Hg and morning or evening HBP \<135/85 mm Hg, respectively.^[@CIT0017]^

Other assessments and seasonal factors {#s4}
--------------------------------------

Medical history was obtained by medical records and direct interviews. The diagnosis of diabetes mellitus was defined as a self-reported history, diabetic medication use, fasting or non-fasting blood glucose level ≥126 mg/dl, or ≥200 mg/dl, respectively. Chronic kidney disease was defined as the presence of proteinuria or estimated glomerular filtration rate \<60 ml/min/1.73 m^2^.^[@CIT0018]^ Prevalent CVD included diagnosed angina pectoris, myocardial infarction, and cerebrovascular disease at enrollment. In addition, the methods used to measure biomarker assays are described in [Supplementary Materials](#sup2){ref-type="supplementary-material"} online. Blood and spot urine samples were collected in the morning in a fasting state at study enrollment. The seasons were defined as follows: spring ranged from March 1 to May 31; summer, June 1--August 31; autumn, September 1--November 30; and winter, December 1--the last day of next year's February.^[@CIT0019]^ Participants were classified according to whether their first day of HBP measurements occurred in each season. Subsequently, because Japan spans a wide latitude, various environmental factors, such as temperature, differ from region to region. Hence, we also assessed seasonal variations in BP parameters and their associations with TOD in each region. We divided the participating institutions into four regions: Northern (*N* = 341); Eastern (*N* = 1,742); Central (*N* = 1,144); and Western (*N* = 1,040), as shown in [Supplementary Figure S1](#sup1){ref-type="supplementary-material"} online.

Statistical analysis {#s5}
--------------------

Statistical analysis was performed using SPSS version 19.0 (SPSS Inc., Chicago, IL) and EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), which is a graphical interface for R (The R Foundation for Statistical Computing, Vienna, Austria).^[@CIT0017]^ Data are shown as the mean ± SD (continuous variables) or as percentages (categorical variables). Normally distributed continuous data were compared using Student's *t*-test, and categorical data were assessed using the Chi-squared test. In addition, multiple comparisons were performed using analysis of variance and using Bonferroni correction. To assess the independent effect of each season on BP levels, we performed multivariable linear regression analysis defined summer as reference. Covariates included traditional risk factors such as age, sex, body mass index, current smoking, alcohol consumption, diabetes, dyslipidemia, chronic kidney disease, antihypertensive medication use, and pre-existing CVD. The models of morning or evening home systolic or diastolic BP (SBP/DBP) also included office SBP or DBP, respectively. To determine the independent effects of each season on the presence of masked and white-coat hypertension, multivariable logistic regression analysis was performed after adjusting for traditional risk factors. We performed multivariable linear regression analysis for the association between BP levels and TOD in each season. Because the distributions of the UACR and BNP were highly skewed, they were log-transformed for the analysis. In the model of office BP, covariates included traditional risk factors, and office SBP/DBP were added to the model of morning or evening home SBP/DBP, respectively. An analysis of interaction was performed to detect the difference in the association between BP parameters and log-transformed UACR or BNP between a targeted season and the other seasons using multivariable linear regression. The levels of statistical significance were established at a two-sided *P* value \<0.05 for all tests.

RESULTS {#s6}
=======

Patients' characteristics {#s7}
-------------------------

The 4,267 participants were used for the present analysis from the J-HOP study. In whole participants, the mean age was 64.9 ± 10.9 years, and 46.9% were men, and 91.4% were hypertensive patients ([Supplementary Table S1](#sup2){ref-type="supplementary-material"} online). [Table 1](#T1){ref-type="table"} lists the participants' characteristics in each season. Most of the host factors, such as sex, prevalence of diabetes, chronic kidney disease, and antihypertensive medication use, did not differ among seasons. Additionally, log-transformed UACR was lower in summer than autumn and winter. Log-transformed BNP was higher in summer than spring and winter.

###### 

Characteristics of the 4,267 study participants according to season assignment

  Descriptive variables (participants, *N*)               Spring (*N* = 1,060)   Summer (*N* = 979)    Autumn (*N* = 1,224)   Winter (*N* = 1,004)   *P* for trend
  ------------------------------------------------------- ---------------------- --------------------- ---------------------- ---------------------- ---------------
  Age, years                                              65.6 ± 10.7            64.5 ± 11.0           65.1 ± 11.3            64.2 ± 10.6\*          0.018
  Male, %                                                 45.3                   45.2                  47.1                   50.0                   0.023
  BMI, kg/m^2^                                            24.4 ± 3.5             24.3 ± 3.3            24.2 ± 3.6             24.3 ± 3.5             0.781
  Current smoking, %                                      11.8                   11.3                  13.3                   12.5                   0.369
  Hypertension, %                                         93.2                   87.6\*                91.8^†^                92.7^†^                0.559
  Use of antihypertensive medication, %                   79.3                   77.4                  79.7                   79.7                   0.527
  Number of classes of antihypertensive medication, *N*   1.60 ± 1.18            1.52 ± 1.20           1.54 ± 1.14            1.57 ± 1.17            0.862
  Diabetes mellitus, %                                    23.2                   25.2                  25.7                   23.2                   0.869
  CKD, %                                                  21.9                   23.0                  24.7                   20.8                   0.875
  Statin treatment, %                                     20.5                   25.6\*                25.0                   23.5                   0.126
  Pre-existing CVD, %                                     10.0                   14.1\*                13.0                   13.9\*                 0.018
  Serum and urine biomarkers                                                                                                                         
   Fasting glucose, mg/dl                                 107.0 ± 28.6           107.3 ± 27.6          107.5 ± 27.5           108.2 ± 26.6           0.025
   Total cholesterol, mg/dl                               203.2 ± 32.1           199.5 ± 33.2          201.8 ± 33.3           205.4 ± 33.5^†^        0.105
   HDL cholesterol, mg/dl                                 57.5 ± 15.3            55.8 ± 14.7           57.6 ± 15.3^†^         59.3 ± 15.6\* ^,†,‡^   \<0.001
   UACR, mg/g Cr                                          13.2 (7.1, 29.1)       12.3 (6.8, 25.7)      13.8 (7.4, 35.2)       13.4 (7.5, 32.8)       
    Log UACR^a^                                           1.12 (0.85, 1.46)      1.09 (0.83, 1.41)     1.14 (0.87, 1.55)^†^   1.13 (0.88, 1.52)^†^   0.029
   BNP, pg/ml                                             18.6 (9.0, 36.9)       19.5 (9.4, 43.2)      19.3 (9.6, 39.6)       17.3 (8.9, 34.7)       
    Log BNP^a^                                            1.27 (0.95, 1.57)      1.29 (0.97, 1.64)\*   1.29 (0.98, 1.60)      1.24 (0.95, 1.54)^†^   0.301
  Office and home BP parameters                                                                                                                      
   Office SBP, mm Hg                                      142.5 ± 18.0           139.4 ± 18.5\*        141.0 ± 18.3           141.6 ± 18.5           0.757
   Office DBP, mm Hg                                      81.6 ± 11.3            80.8 ± 11.3           82.1 ± 11.4            82.4 ± 11.6            0.020
   Morning home SBP, mm Hg                                139.4 ± 15.5           134.1 ± 15.6\*        139.3 ± 16.1^†^        140.3 ± 15.5^†^        \<0.001
   Morning home DBP, mm Hg                                79.2 ± 9.8             77.3 ± 10.0\*         79.5 ± 10.2^†^         80.3 ± 9.8^†^          \<0.001
   Evening home SBP, mm Hg                                131.9 ± 14.9           126.7 ± 14.1\*        130.4 ± 15.2^†^        131.3 ± 15.2^†^        0.551
   Evening home DBP, mm Hg                                73.2 ± 9.4             71.0 ± 9.4\*          72.9 ± 10.0^†^         73.5 ± 9.7^†^          0.058

Data are expressed as mean ± SD or percentage. UACR and BNP are expressed as median (interquartile range). Pre-existing CVD includes angina pectoris, acute myocardial infarction, and stroke. Statistical significance was assessed using analysis of variance for parametric and categorical data, and Bonferroni correction for multiple comparisons. *P* values for trend in this table were calculated by Jonckheere--Terpstra's test for continuous data and Cochran--Armitage trend test for categorical data. Statistical significance was defined as *P* \< 0.05; statistical significant in seasonal differences: \*vs. Spring, ^†^vs. summer, and ^‡^vs. autumn. Abbreviations: BMI, body mass index; BNP, b-type natriuretic peptide; BP, blood pressure; CKD, chronic kidney disease; CVD, cardiovascular disease; DBP, diastolic blood pressure; HDL, high-density lipoprotein; SBP, systolic blood pressure; UACR, urine albumin creatinine ratio.

^a^Multiple comparisons and *P* values for trend were calculated in log-transformed UACR and BNP.

Seasonal BP variation {#s8}
---------------------

[Figure 1](#F1){ref-type="fig"} demonstrates the seasonal variation of office, morning, and evening HBP. Office SBP was lower in summer only compared with spring, and office DBP exhibited no significant difference in each season. Whereas, morning home SBP and DBP were significantly lower in summer compared with other seasons. Evening home SBP and DBP were also significantly lower in summer than the other seasons. These BP values are also shown in [Table 1](#T1){ref-type="table"}. [Table 2](#T2){ref-type="table"} shows the multivariable linear regression analysis of each BP parameter adjusted for host factors. Because both office and HBP levels tended to be lower in summer than the other seasons, we defined summer as a reference. Both morning and evening home SBP/DBP were also higher in other seasons than in summer after adjusting for host factors and office SBP/DBP, and the estimate value was higher in winter than other seasons in both morning and evening home SBP/DBP. Additionally, in each divided region except the Northern one, morning and evening HBP levels also tended to be lower in summer than in the other seasons ([Supplementary Table S2](#sup2){ref-type="supplementary-material"} online).

###### 

Multivariable linear regression analysis for office and home BP in the 4,267 study participants

  Dependent variables   Office SBP                     Morning home SBP              Evening home SBP    
  --------------------- ------------------- ---------- ------------------- --------- ------------------- ---------
  Spring                2.86 (1.28--4.44)   \< 0.001   3.73 (2.56--4.91)   \<0.001   3.98 (2.84--5.11)   \<0.001
  Summer                Ref.                           Ref.                          Ref.                
  Autumn                1.56 (0.03--3.09)   0.046      4.31 (3.18--5.45)   \<0.001   3.03 (1.94--4.13)   \<0.001
  Winter                2.32 (0.72--3.92)   0.005      5.39 (4.20--6.57)   \<0.001   4.06 (2.92--5.21)   \<0.001
  *R* ^2^               0.024                          0.280                         0.250               
  Dependent variables   Office DBP                     Morning home DBP              Evening home DBP    
  Seasons               *B* (95% CI)        *P*        *B* (95% CI)        *P*       *B* (95% CI)        *P*
  Spring                1.13 (0.22--2.04)   0.015      1.49 (0.84--2.19)   \<0.001   1.88 (1.22--2.54)   \<0.001
  Summer                Ref.                           Ref.                          Ref.                
  Autumn                1.56 (0.69--2.44)   \<0.001    1.53 (0.91--2.16)   \<0.001   1.43 (0.79--2.07)   \<0.001
  Winter                1.37 (0.45--2.29)   0.003      2.02 (1.36--2.67)   \<0.001   1.88 (1.21--2.55)   \<0.001
  *R* ^2^               0.170                          0.452                         0.391               

All analyses were adjusted for host factors (age, sex, body mass index, prevalent CVD, current smoking, alcohol consumption, diabetes, dyslipidemia, chronic kidney disease, and use of antihypertensive medications). Additionally, office SBP or office DBP was included in analysis of morning and evening home SBP or DBP, respectively. These analyses were assessed by using multivariate linear regression analysis. *B* and *R*^2^ indicate the nonstandardized coefficient and coefficient of determination, respectively. Abbreviations: BP, blood pressure; CI, confidence interval; CVD, cardiovascular disease; DBP, diastolic blood pressure; SBP, systolic blood pressure.

![Office and home blood pressure levels in each season. Office and home BP were compared for each season, using analysis of variance and Bonferroni correction for multiple comparisons. Statistical significance was defined as *P* \< 0.05, and black and white points in this figure indicate SBP and DBP levels, respectively. \**P* \< 0.05, \*\**P* \< 0.001, error bar represents 1 − SD. In this figure, BP, DBP, SBP, and SD indicate blood pressure, diastolic blood pressure, systolic blood pressure, and standard deviation, respectively.](hpaa027f0001){#F1}

The prevalence of masked hypertension and white-coat hypertension in each season {#s9}
--------------------------------------------------------------------------------

[Figure 2](#F2){ref-type="fig"} shows seasonal variations in the prevalence of masked hypertension in participants with well-controlled office BP (\<140/90 mm Hg, *N* = 1,959) and the prevalence of white-coat hypertension in participants with elevated office BP (≥140/90 mm Hg, *N* = 2,308). The prevalence of masked morning and evening hypertension was significantly lower in summer than in the other seasons (all *P* \< 0.05). Moreover, approximately 50% of patients with well-controlled had masked hypertension defined by morning HBP. In contrast, the prevalence of white-coat hypertension defined by either morning or evening HBP was significantly higher in summer than the other seasons (all *P* \< 0.05). When summer was defined as a reference, the other seasons were associated with a significantly higher risk of the presence of masked hypertension after adjustment for host factors, irrespective of whether the assessment was made using morning or evening HBP ([Table 3](#T3){ref-type="table"}). Moreover, the other seasons were associated with a lower risk of the presence of white-coat morning and evening hypertension compared with summer as a reference ([Table 3](#T3){ref-type="table"}).

###### 

Multivariable logistic regression analysis of the prevalence of masked hypertension and white-coat hypertension in each season

  Participants with normal office BP (\<140/90 mm Hg), *N* = 1,959                                                                                                          
  ------------------------------------------------------------------- ----------------------- --------------------- --------- ----------------------- --------------------- ---------
  Spring                                                              213/455                 1.90 (1.45--2.50)     \<0.001   132/455                 2.06 (1.48--2.87)     \<0.001
  Summer                                                              155/501                 Ref.                            84/501                  Ref.                  
  Autumn                                                              247/562                 1.78 (1.38--2.31)     \<0.001   140/562                 1.56 (1.13--2.16)     0.007
  Winter                                                              226/441                 2.36 (1.79--3.10)     \<0.001   111/441                 1.76 (1.26--2.47)     0.001
  Participants with elevated office BP (≥140/90 mm Hg), *N* = 2,308                                                                                                         
                                                                      White-coat morning HT                                   White-coat evening HT                         
                                                                      Event/number            Odds ratio (95% CI)   *P*       Event/number            Odds ratio (95% CI)   *P*
  Spring                                                              174/605                 0.68 (0.52--0.88)     \<0.001   304/605                 0.61 (0.47--0.78)     \<0.001
  Summer                                                              181/478                 Ref.                            296/478                 Ref                   
  Autumn                                                              177/662                 0.62 (0.48--0.80)     \<0.001   335/662                 0.60 (0.46--0.77)     \<0.001
  Winter                                                              143/563                 0.55 (0.42--0.72)     \<0.001   283/563                 0.56 (0.43--0.73)     \<0.001

Masked morning or evening HT was defined as office BP \<140/90 mm Hg and masked morning or evening home BP ≥135/85 mm Hg; white-coat HT was defined as office BP \>140/90 mm Hg and morning or evening home BP \<135/85 mm Hg. The traditional host factors (age, sex, body mass index, prevalent CVD, current smoking, alcohol consumption, diabetes, dyslipidemia, chronic kidney disease, and use of antihypertensive medications) were adjusted by using multivariate logistic regression analysis. Abbreviations: BP, blood pressure; CI, confidence interval; CVD, cardiovascular disease; HT, hypertension.

![Prevalence of masked hypertension and white-coat hypertension in each season. The upper part of this figure shows the comparison of the prevalence of masked HT between seasons in 1,959 participants who had well-controlled office BP (\<140/90 mm Hg). The lower part of this figure shows the comparison of the prevalence of white-coat HT between seasons in 2,308 participants who had elevated office BP (≥140/90 mm Hg). These comparisons were analyzed using analysis of variance and Bonferroni correction for multiple comparisons. Masked morning and evening HT were defined as elevated morning or evening home BP ≥ 135/85 mm Hg in patients with well-controlled office BP. White-coat HT was defined as morning or evening home BP \<135/85 mm Hg in patients with elevated office BP. These definitions were based on the 2014 Japanese guidelines. \**P* \< 0.05, \*\**P* \< 0.001. In this figure, BP and HT indicate blood pressure and hypertension, respectively.](hpaa027f0002){#F2}

Association between BP and TOD according to season {#s10}
--------------------------------------------------

[Table 4](#T4){ref-type="table"} shows the results of the multivariate linear regression analysis of BP parameters for log-transformed UACR and BNP adjusted for host factors in winter and other seasons. Although all BP parameters were associated with log-transformed UACR in winter, there was an interaction between office, morning, or evening home DBP and log-transformed UACR according to winter and other seasons (all *P* for interaction \<0.05). There were no interactions between BP parameters and log-transformed UACR in the spring, summer, and autumn models ([Supplementary Table S3](#sup2){ref-type="supplementary-material"} online). According to BNP, in winter, there was a significant association between morning home DBP and log-transformed BNP, but this association was not observed in the other seasons ([Table 4](#T4){ref-type="table"} and [Supplementary Table S4](#sup2){ref-type="supplementary-material"} online). There was an interaction between morning home DBP and log-transformed BNP according to winter and other seasons (*P* for interaction = 0.011). Although morning home SBP was significantly associated with log-transformed BNP in each season, the interaction between morning home SBP and log-transformed BNP was observed only in the model of autumn (*P* for interaction = 0.049) ([Supplementary Table S4](#sup2){ref-type="supplementary-material"} online).

###### 

Coefficient values (95% confidence interval) of blood pressure parameters for UACR and BNP of winter vs. other seasons

  BP parameters                UACR                                                BNP                       
  ---------------------------- ------------------------- ------------------------- ------------------------- ----------------------------
  Office SBP, 10 mm Hg         0.047^†^ (0.030, 0.064)   0.056^†^ (0.046, 0.065)   0.002 (−0.012, 0.015)     0.014^†^ (0.007, 0.022)
                               *P* ~int~ = 0.233                                   *P* ~int~ = 0.095         
  Office DBP, 10 mm Hg         0.078^†^ (0.048, 0.108)   0.052^†^ (0.035, 0.068)   −0.014 (−0.037, 0.010)    −0.024^†^ (−0.037, −0.010)
                               *P* ~int~ = 0.039                                   *P* ~int~ = 0.343         
  Morning home SBP, 10 mm Hg   0.068^†^ (0.045, 0.092)   0.066^†^ (0.053, 0.078)   0.046^†^ (0.028, 0.065)   0.028^†^ (0.018, 0.038)
                               *P* ~int~ = 0.270                                   *P* ~int~ = 0.445         
  Morning home DBP, 10 mm Hg   0.092^†^ (0.051, 0.133)   0.052^†^ (0.029, 0.075)   0.044^†^ (0.012, 0.076)   0.004 (−0.019, 0.020)
                               *P* ~int~ = 0.008                                   *P* ~int~ = 0.011         
  Evening home SBP, 10 mm Hg   0.046^†^ (0.023, 0.070)   0.057^†^ (0.045, 0.070)   0.013 (−0.005, 0.032)     0.014\* (0.003, 0.024)
                               *P* ~int~ = 0.143                                   *P* ~int~ = 0.798         
  Evening home DBP, 10 mm Hg   0.057^†^ (0.016, 0.097)   0.042^†^ (0.019, 0.064)   −0.007 (−0.038, 0.025)    −0.026^†^ (−0.045, −0.007)
                               *P* ~int~ = 0.044                                   *P* ~int~ = 0.076         

This table shows the nonstandardized coefficient (95% confidence interval) of each BP parameter for log-transformed UACR and BNP in multivariable linear regression models in the subjects in winter (*N* = 1,004) vs. other seasons (*N* = 3,263). The models for office BPs included traditional host factors (age, sex, body mass index, prevalent CVD, current smoking, alcohol consumption, diabetes, dyslipidemia, chronic kidney disease, and use of antihypertensive medications). The model for morning or evening home BPs included traditional host factors and office SBP or DBP. The values of *P* for interaction were calculated from the analysis model in all participants (*N* = 4,267), which included each BP parameter, winter (vs. other seasons), the interaction between each BP parameter and winter (vs. other seasons), and traditional host factors. Abbreviations: BNP, b-type natriuretic peptide; BP, blood pressure; CVD, cardiovascular disease; DBP, diastolic blood pressure; SBP, systolic blood pressure; UACR, urine albumin creatinine ratio. *P*~int~ = *P* for interaction.

\**P* \< 0.05.

^†^ *P* \< 0.01.

In addition, the *P* value for interaction in the multivariate linear regression models of morning home DBP with log-transformed UACR was significant, and with log-transformed BNP, the *P* value was marginally significant in the comparison between winter and other seasons even after adjustment using Bonferroni's correction (*P* for interaction between morning home DBP and winter for log-transformed UACR, *P* for interaction = 0.048; for log-transformed BNP, *P* for interaction = 0.066).

The results of the multivariate linear regression analysis of each BP parameter for log-transformed UACR and BNP in winter vs. other seasons were also assessed in each divided region. The coefficient values of morning home DBP for both log-transformed UACR and BNP tended to be higher in winter than in the other seasons. However, there were no significant interactions between each BP parameter and both log-transformed UACR and BNP in the regional models ([Supplementary Tables S5 and S6](#sup2){ref-type="supplementary-material"} online).

Discussion {#s11}
==========

The summary of the results in this study is as follows. (i) Morning and evening HBP were lower in summer than in the other seasons after adjustment for host factors. (ii) The prevalence of masked hypertension was significantly lower in summer than in the other seasons even after adjusting for host factors. (iii) There was an interaction between morning home DBP and TODs such as UACR and BNP according to winter and other seasons after adjustment for host factors and its BP level. To the best of our knowledge, this is the first study to observe that the relationship between HBP and TOD was higher specifically in winter.

Seasonal variation of morning HBP {#s12}
---------------------------------

In the present study, defined summer as reference, the coefficient of morning home SBP in winter was higher than that of either office or evening home SBP in winter. Iwahori *et al.* reported a cohort study assessing the same subjects, morning and evening HBP were lower in summer and higher in winter,^[@CIT0014]^ but the participants had relatively low cardiovascular risks, and more than half of the participants had not received hypertensive treatment. However, most of our participants were hypertensives (91.4%) and had one or more cardiovascular risks. Although our study was a cross-sectional study, our findings suggested that morning HBP was also lower in summer and higher in winter even in participants with relatively high cardiovascular risk in a practice setting.

Sympathetic nervous and renin--angiotensin systems are activated in morning, which is generally considered the reason of elevated BP in morning.^[@CIT0020],[@CIT0021]^ Moreover, morning HBP level is associated with outside temperature,^[@CIT0022]^ and lowering temperature activates sympathetic nervous systems with BP elevation.^[@CIT0023]^ As a result, morning HBP may be strongly affected by the cold temperature in winter.

Masked and white-coat hypertension in each season {#s13}
-------------------------------------------------

In the present study, the prevalence of masked hypertension was significantly higher in other seasons than in summer. Masked hypertension is recognized as an important CVD risk.^[@CIT0024]^ We revealed that masked hypertension diagnosed by morning HBP was a risk factor for stroke in clinical practice.^[@CIT0026]^ Moreover, approximately 50% of our patients with well-controlled office BP had uncontrolled morning HBP in winter. This winter increase in the proportion of patients with masked hypertension may be associated with the increased winter mortality from CVD. Subsequently, the prevalence of white-coat hypertension was higher in summer than other seasons in the present study. Especially in summer, referring only to office BP level, it is difficult for physicians to adjust the dose of antihypertensives, which may lead to adverse events due to hypotension.

Winter increase in the association between HBP and TOD {#s14}
------------------------------------------------------

In our multivariable analysis with each season defined as a reference, relationships between morning home DBP and TODs such as UACR or BNP were noted in winter. To the best of our knowledge, this is the first study to demonstrate a seasonal difference in the relationship between HBP and TOD. We previously reported that morning HBP had a greater correlation with TOD than evening HBP.^[@CIT0007]^ The findings of the current study provide adding information that there was a seasonal variation about the association between morning HBP level and TOD.

In our participants, office, morning, and evening home DBP were more strongly associated with UACR in winter compared with other seasons. However, the relationship of all BP parameters with UACR did not exhibit any seasonal changes in spring, summer, or autumn. These results indicated that BP parameters in winter might be a more important marker for renal dysfunction than that in other seasons. Though UACR has been reported to increase in winter in diabetes,^[@CIT0027]^ in our study the elevated BP levels in winter seemed to have a stronger effect on UACR than that in other seasons. Moreover, increases in proteinuria relative to UACR are widely recognized as important risk factors for progression to renal failure.^[@CIT0028],[@CIT0029]^ Based on our findings, increased BP levels especially in winter may contribute to the progression of chronic kidney disease.

Our multivariable linear regression models revealed the differences in the interaction between morning home DBP and log-transformed BNP according to winter vs. other seasons. Exacerbations of heart failure increase in winter,^[@CIT0030]^ and plasma natriuretic peptide which is related to cardiovascular outcomes has been reported to present a mild elevation in winter.^[@CIT0031],[@CIT0032]^ Thus, these previous findings, when taken together with our present results, might explain the increased incidence of heart failure in winter. From our observation of a strong relationship between morning home DBP and BNP in winter, elevated morning HBP in winter might constitute a risk factor for the progression of hypertensive heart disease.

Study limitations {#s15}
-----------------

The strengths of this study include its recruitment from a nationwide and the inclusion of a large number of clinical practice patients with CVD risk factors. Moreover, we used the same validated device to measure HBP, applied standardized HBP measurement schedules, and had a high patient retention rate. However, this study also has some potential limitations. The most notable was that our observations were cross-sectional BP profiles of participants in each season---that is, we did not conduct HBP monitoring for the same subjects throughout the four seasons. Additionally, various environmental factors differ regionally in Japan, and these differences might affect the seasonal variation of BP. Thus, we also analyzed the seasonal variation of BP parameters in each region in Japan.

In the present study, seasonal variation of HBP was characterized as a fall in summer compared with other seasons. About half of patients with well-controlled office BP were actually diagnosed with masked morning hypertension in winter. Moreover, we revealed that the relationship between morning HBP and TOD was stronger in winter than in the other seasons. In conclusion, intensive management of hypertension using HBP measurements might be useful to prevent the progression of organ damages such as renal dysfunction and heart failure, especially in winter.
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